Nature's Sunshine Products (NASDAQ:NATR - Get Free Report) released its quarterly earnings results on Tuesday. The company reported $0.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.19 by $0.11, FiscalAI reports. The firm had revenue of $123.81 million during the quarter, compared to analyst estimates of $121.62 million. Nature's Sunshine Products had a net margin of 3.18% and a return on equity of 10.86%.
Nature's Sunshine Products Stock Performance
Shares of NATR stock traded down $0.05 during trading hours on Tuesday, hitting $25.08. 134,778 shares of the company were exchanged, compared to its average volume of 125,213. The company has a 50 day simple moving average of $24.83 and a two-hundred day simple moving average of $20.28. The firm has a market cap of $438.90 million, a P/E ratio of 30.96 and a beta of 0.93. Nature's Sunshine Products has a fifty-two week low of $11.01 and a fifty-two week high of $28.14.
Insider Transactions at Nature's Sunshine Products
In related news, EVP Bryant J. Yates sold 1,700 shares of the stock in a transaction on Friday, December 12th. The shares were sold at an average price of $22.29, for a total transaction of $37,893.00. Following the transaction, the executive vice president directly owned 98,604 shares of the company's stock, valued at $2,197,883.16. This represents a 1.69% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 5.60% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Nature's Sunshine Products
Several institutional investors have recently made changes to their positions in the stock. Boston Partners bought a new position in shares of Nature's Sunshine Products during the 4th quarter worth about $4,544,000. Manatuck Hill Partners LLC bought a new stake in Nature's Sunshine Products in the 2nd quarter valued at about $1,923,000. Vanguard Group Inc. raised its stake in Nature's Sunshine Products by 15.3% during the 3rd quarter. Vanguard Group Inc. now owns 803,104 shares of the company's stock worth $12,464,000 after buying an additional 106,688 shares during the period. Kennedy Capital Management LLC raised its stake in Nature's Sunshine Products by 14.6% during the 3rd quarter. Kennedy Capital Management LLC now owns 675,764 shares of the company's stock worth $10,488,000 after buying an additional 86,128 shares during the period. Finally, Two Sigma Investments LP boosted its holdings in Nature's Sunshine Products by 215.5% in the third quarter. Two Sigma Investments LP now owns 119,798 shares of the company's stock worth $1,859,000 after acquiring an additional 81,830 shares in the last quarter. Institutional investors and hedge funds own 79.40% of the company's stock.
Analyst Upgrades and Downgrades
NATR has been the subject of several recent analyst reports. Weiss Ratings reiterated a "hold (c+)" rating on shares of Nature's Sunshine Products in a research report on Monday, December 29th. DA Davidson upped their price target on shares of Nature's Sunshine Products from $21.00 to $23.00 and gave the company a "buy" rating in a research report on Monday, November 10th. Finally, Canaccord Genuity Group lifted their price objective on Nature's Sunshine Products from $22.00 to $29.00 and gave the stock a "buy" rating in a research report on Tuesday. Two analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $26.00.
Read Our Latest Analysis on NATR
About Nature's Sunshine Products
(
Get Free Report)
Nature’s Sunshine Products, Inc is a global manufacturer and direct seller of nutritional supplements, herbal remedies, and personal care products. The company’s core business centers on research, development and distribution of vitamins, minerals, botanicals and essential oil-based formulations designed to support overall health and wellness. Operating under a network-marketing model, Nature’s Sunshine works through a network of independent distributors who promote and sell its product line directly to consumers.
The company’s product portfolio spans dietary supplements such as single-ingredient vitamins, proprietary herbal blends, sports nutrition formulas and weight-management solutions, along with skin and hair care items based on botanical extracts and essential oils.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nature's Sunshine Products, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nature's Sunshine Products wasn't on the list.
While Nature's Sunshine Products currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
